The British HIV Association (BHIVA) was founded in 1995 and is recognized as the leading United Kingdom association representing professionals in HIV care. BHIVA is dedicated to promoting optimal outcomes for people affected by and living with HIV through the development and distribution of clinical guidelines. 

Not only does BHIVA provide guidance for clinicians, but it does so for people living with HIV, as well. BHIVA provides non-technical summaries of guidelines for patients and their families, patient information leaflets, and more.

December 1 is recognized as World AIDS Day. In recognition of the awareness day, we wanted to feature BHIVA and some of the guidance they recently published along with their provided descriptions or brief summaries of the recommendations they contain. The following is a look at recent guidance and recommendations that BHIVA provides to clinicians regarding people living with HIV.

Management of HIV in Pregnancy and the Postpartum Period

  • Published June 2025
  • Description: These clinical guidelines have been produced to help ensure women/birthing parents living with human immunodeficiency virus (HIV) are supported to maintain optimal health for themselves during pregnancy and the postpartum period, and the health and wellbeing of their infant(s).

Management of Opportunistic Infection in People Living with HIV: The Clinical Management of Non-Tuberculous Mycobacteria

  • Published December 2024
  • Description: This guideline focuses on non-tuberculous mycobacteria (NTM) and includes recommendations on prophylaxis and impact of antiretroviral therapy, treatment of disseminated Mycobacterium avium complex disease, diagnosis of M. kansasii disease, and treatment of M. kansaii disease. 

Management of Opportunistic Infection in People Living with HIV: Considerations in Pregnancy

  • May 2024
  • Description: Recommendations in this guideline focus on the treatment of pneumocystis jirovecii pneumonia, cryptococcal infection, CMV, mycobacterium avium complex, and associated neonatal considerations.

Management of Opportunistic Infection in People Living with HIV: Clinical Investigation and Management of Pyrexia of Unknown Origin

  • November 2023
  • Description: Now that the majority of people living with HIV take combination antiretroviral therapy (ART), the spectrum of causes of pyrexia of unknown origin (PUO) has changed compared with the pre-ART era. In these guidelines, [BHIVA] focus on causes and evaluation of PUO among people living with HIV with CD4 counts <350 cells/mm3.

Antiretroviral Treatment for Adults Living with HIV-1

  • November 2023
  • Description: The overall purpose of these guidelines is to provide guidance on best clinical practice for antiretroviral therapy (ART) and management of adults living with human immunodeficiency virus (HIV). The scope includes: 1.) Guidance on the initiation of ART in those previously naïve to therapy; 2.) Support of people living with HIV on treatment; 3.) Management of individuals experiencing virological failure; 4.) Switch for tolerability and/or toxicity issues; and 5.) Recommendations for specific populations where other factors need to be taken into consideration.

Sign up for alerts and stay informed on the latest published guidelines and articles.

Copyright © 2025 Guideline Central, all rights reserved.